Stilboestrol and human cancer.
D000014:Abnormalities, Drug-Induced / Q000473:pathology; D000230:Adenocarcinoma / Q000139:chemically induced*; D000293:Adolescent; D000328:Adult; D001943:Breast Neoplasms / Q000139:chemically induced; D002273:Carcinogens; D002294:Carcinoma, Squamous Cell / Q000139:chemically induced; D002584:Cervix Uteri / Q000002:abnormalities; D003560:Cysts / Q000139:chemically induced; D004054:Diethylstilbestrol / Q000009:adverse effects*; D004822:Epididymis / Q000002:abnormalities; D005260:Female; D006801:Humans; D008297:Male; D008431:Maternal-Fetal Exchange; D011230:Precancerous Conditions / Q000139:chemically induced; D011247:Pregnancy; D013723:Teratogens; D002583:Uterine Cervical Neoplasms / Q000139:chemically induced; D014621:Vagina / Q000002:abnormalities; D014625:Vaginal Neoplasms / Q000139:chemically induced*
D002273:Carcinogens; D013723:Teratogens; D004054:Diethylstilbestrol